ODDITY Tech Ltd. announced record financial results for the second quarter ended June 30, 2025, continuing its trend of exceeding expectations. Net revenue for Q2 2025 reached $241 million, a 25% increase year-over-year. The company reported adjusted EBITDA of $70 million and adjusted diluted EPS of $0.88.
Following these strong results, ODDITY once again raised its full-year 2025 financial outlook. The company now anticipates net revenue between $799 million and $804 million, adjusted EBITDA between $160 million and $162 million, and adjusted diluted EPS between $2.06 and $2.09. This marks a consistent upward revision of guidance throughout the year.
A significant strategic update included the upcoming launch of Brand 3, named METHODIQ, in the fourth quarter of 2025. This new brand represents ODDITY's expansion into medical-grade products, specifically a telehealth platform for dermatology, which is expected to open a massive new market for the company.
For the third quarter ending September 30, 2025, ODDITY provided guidance expecting net revenue between $120 million and $122 million, and adjusted diluted EPS between $0.30 and $0.32. Management emphasized that the remainder of the year is largely driven by a high visibility backlog of repeat orders, contributing to confidence in the raised outlook.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.